Proton Pump Inhibitor (PPI)
Showing 1 - 25 of >10,000
Eosinophilic Esophagitis Trial in Aurora (Omeprazole 20mg BID)
Recruiting
- Eosinophilic Esophagitis
- Omeprazole 20mg BID
-
Aurora, ColoradoChildren's Hospital Colorado
Jul 28, 2022
GERD Trial in Manchester (Body Surface Gastric Mapping)
Recruiting
- GERD
- Body Surface Gastric Mapping
-
Manchester, Greater Manchester, United KingdomThe Functional Gut Clinic
Jan 31, 2023
Delirium Related to Proton Pump Inhibitors Use
Completed
- Proton Pump Inhibitor Adverse Reaction
- +2 more
-
Caen, FranceCaen University Hospital
Apr 17, 2023
Healthy Volunteers Trial in Daytona Beach (LOXO-305, Omeprazole)
Completed
- Healthy Volunteers
-
Daytona Beach, FloridaCovance Clinical Research Unit
Nov 23, 2021
Post Prandial High Resolution Impedance- Manometry
Recruiting
- Gastro-esophageal Reflux
- Correlating the number of reflux episodes detected on 1-h post prandial esophageal high resolution manometry combined and those detected on ambulatory 24-h pH-impedance monitoring performed on PPI
-
Lyon, FranceExploration Fonctionnelle Digestive, Hôpital Edouard Herriot, Ly
Mar 17, 2022
Intrahepatic Cholangiocarcinoma Trial in Shanghai (HMPL-453, Rabeprazole)
Active, not recruiting
- Intrahepatic Cholangiocarcinoma
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
Jun 24, 2023
Heartburn, Dyspepsia, Reflux Trial in Leuven (de-prescription of PPI via intermittent scheme, de-prescription of PPI via
Not yet recruiting
- Heartburn
- +2 more
- de-prescription of PPI via intermittent scheme
- +2 more
-
Leuven, Vlaams Brabant, BelgiumJan Tack
Nov 16, 2022
Non-erosive Reflux Disease, Gastroesophageal Reflux Trial in New Orleans (Proton Pump Inhibitor (PPI) Therapy, Sucralfate)
Terminated
- Non-erosive Reflux Disease
- Gastroesophageal Reflux
- Proton Pump Inhibitor (PPI) Therapy
- Sucralfate
-
New Orleans, Louisiana
- +1 more
Jan 25, 2022
Hypothyroidism;Postablative Trial in United States (levothyroxine sodium capsule, Proton pump inhibitor (PPI), Levothyroxine
Completed
- Hypothyroidism;Postablative
- levothyroxine sodium capsule
- +2 more
-
La Jolla, California
- +8 more
Apr 1, 2022
Gastric Lesion, Proton Pump Inhibitor Adverse Reaction, Probiotic Trial in Bari (Gastrus, Placebo)
Recruiting
- Gastric Lesion
- +2 more
- Gastrus
- Placebo
-
Bari, ItalyFernanda
Jul 29, 2022
Helicobacter Pylori Infection, Early Gastric Cancer, Endoscopic Resection Trial in Goyang (7 day H.pylori eradication Omeprazole
Active, not recruiting
- Helicobacter Pylori Infection
- +2 more
- 7 day H.pylori eradication Omeprazole or Rabeprazole, Clarithromycin, Amoxicillin
- Placebo, Omeprazole or Rabeprazole, Clarithromycin
-
Goyang, Gyeonggi, Korea, Republic ofNational Cancer Center, Korea
Apr 8, 2022
Proton Pump Inhibitor, Inappropriate Drug Use, Discontinuation Trial (Patient Journey App, Information folder)
Not yet recruiting
- Proton Pump Inhibitor
- +3 more
- Patient Journey App
- Information folder
- (no location specified)
Apr 20, 2022
H2 Receptor Antagonist and Proton Pump Inhibitor on Positivity
Not yet recruiting
- COVID-19
- No intervention (Retrospective Cohort Observational)
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 6, 2021
Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)
Completed
- Relapsed or Refractory Lymphoma
- Itraconazole 200 mg
- +3 more
-
Miami, FloridaQPS- Miami
Jan 12, 2023
Proton Pump Inhibitors Trial in United States (PPI De-prescribing Program)
Completed
- Proton Pump Inhibitors
- PPI De-prescribing Program
-
West Haven, Connecticut
- +3 more
Mar 7, 2022
Liver Cirrhosis Trial in Hamburg (Placebo, Esomeprazole 20mg)
Recruiting
- Liver Cirrhosis
- Placebo
- Esomeprazole 20mg
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
May 3, 2021
Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Seoul (PPI, P-CAB 25, P-CAB 50)
Recruiting
- Coronary Artery Disease
- +3 more
- PPI
- +2 more
-
Seoul, Korea, Republic ofAsan Medical Center
Mar 6, 2022
Gastroesophageal Reflux Disease (GERD) Trial in Redmond (EsophyX System with SerosaFuse fasteners, PPI)
Completed
- Gastroesophageal Reflux Disease (GERD)
- EsophyX System with SerosaFuse fasteners
- PPI
-
Redmond, WashingtonEndoGastric Solutions
Nov 6, 2020
Proton Pump Inhibitor, Primary Care Trial in Sesto San Giovanni, Milan, Napoli (Educational intervention)
Active, not recruiting
- Proton Pump Inhibitor
- Primary Care
- Educational intervention
-
Sesto San Giovanni, Milan, Italy
- +2 more
Sep 28, 2021
Helicobacter Pylori Infection Trial in Shanghai (Rabeprazole, Bismuth potassium citrate, Metronidazole)
Recruiting
- Helicobacter Pylori Infection
- Rabeprazole
- +3 more
-
Shanghai, Shanghai, ChinaZhongshan Hospital, Fudan University
Aug 20, 2021
Hepatic Encephalopathy Trial in Durham (PPI deprescribing)
Recruiting
- Hepatic Encephalopathy
- PPI deprescribing
-
Durham, North CarolinaDuke University Hospital
Jan 23, 2023
Coronary Artery Disease Trial (Lansoprazole 15 mg)
Not yet recruiting
- Coronary Artery Disease
- Lansoprazole 15 mg
- (no location specified)
Apr 6, 2023
Bioavailability, B-cell Lymphoid Cancer Trial in Baltimore (Treatment A- Part 1, Treatment B- Part 1, Treatment C - Part 1)
Completed
- Bioavailability
- B-cell Lymphoid Cancer
- Treatment A- Part 1
- +7 more
-
Baltimore, MarylandResearch Site
Feb 2, 2021
Inappropriate Prescribing, Reflux Disease, Proton Pump Inhibitors Trial in Bern (Proton Pump Inhibitor deprescribing tool)
Not yet recruiting
- Inappropriate Prescribing
- +2 more
- Proton Pump Inhibitor deprescribing tool
-
Bern, SwitzerlandProf. Dr. med. Dr. phil. Sven Streit
Nov 8, 2023